HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alpha 1-antitrypsin deficiency in a child with X-linked lymphoproliferative disease.

Abstract
An 18-month-old white male infant with X-linked lymphoproliferative disease was evaluated for persistent hepatic dysfunction following primary Epstein-Barr virus infection. A liver biopsy revealed cirrhosis with a dense mononuclear cell infiltrate. These findings were confounding because cirrhosis is not a typical finding in either normal or immunodeficient individuals following infection with Epstein-Barr virus. An alpha 1-antitrypsin level obtained shortly after biopsy was spuriously within the lower limits of the physiologic range. Further investigation demonstrated a homozygous Z phenotype, the classic protease inhibitor variant described in alpha 1-antitrypsin deficiency. A repeat liver biopsy confirmed the presence of a second hereditary disease. This is a unique concurrence of two uncommon genetic disorders.
AuthorsS Skoda-Smith, E Mroczek-Musulman, C Galliani, T P Atkinson, R G Watts
JournalArchives of pathology & laboratory medicine (Arch Pathol Lab Med) Vol. 121 Issue 9 Pg. 996-9 (Sep 1997) ISSN: 0003-9985 [Print] United States
PMID9302936 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Serine Proteinase Inhibitors
  • alpha 1-Antitrypsin
Topics
  • Genetic Linkage
  • Humans
  • Infant
  • Liver (enzymology, pathology)
  • Liver Cirrhosis (enzymology, etiology, pathology)
  • Lymphoproliferative Disorders (complications, enzymology, genetics)
  • Male
  • Pedigree
  • Serine Proteinase Inhibitors (deficiency, genetics)
  • X Chromosome
  • alpha 1-Antitrypsin (genetics)
  • alpha 1-Antitrypsin Deficiency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: